PFLPhysiological Fitness Landscape

Biomarkers · Anthropometric

Waist-to-Height Ratio (WHtR)

Lower values go with lower risk of death. In NHANES 1999–2018 with linked mortality to 2019, each standard deviation above average goes with 9% higher risk of death. We found the same pattern in NHANES

WHtR and risk of death

NHANES, our fit with 95% CIPublished curve

Published curve higher than the NHANES fitNHANES fit higher

Risk of death relative to each curve's own reference value, so the two curves need not cross 1 at the same point. The dotted vertical line marks the NHANES median.

Risk of death per SD (NHANES)1.09×95% CI 1.06–1.12 · 48,666 adults, 6,727 deaths
Published risk of death1.16×continuous WHtR, per 1 SD increment (95% CI 1.07–1.25) · Random-effects meta-analysis of 20 cohort studies, general population
Value of the measurement+0.012gain in concordance within age bands; rank 29 of 56 · all tests
Across studies, risk per SD1.09×NHANES 1.09 [1.06–1.12] · HRS 1.18 [1.14–1.22]

WHtR across cohorts

11.11.25HR per SD (95% CI)
NHANES · United States, 20–8448,666 people · 6,727 deaths1.09 1.06–1.12
HRS · United States, 50+*23,786 people · 8,247 deaths1.18 1.14–1.22
Risk-of-death ratio per standard deviation, adjusted for age and sex, within each cohort. Cohorts differ in age range, assay, measurement protocol and follow-up, and one SD is a different amount in each, so the comparison is of direction and rough size per SD, not per unit. Vertical line: no association.

* Measured differently from NHANES (see the note on the row); compare direction more than size.

WHtR by age and sex

Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.

The percentiles as a table
Each row is one sex and age band: the values below which 5%, 25%, 50%, 75% and 95% of people fall (ratio), from the survey named in the row. Not a reference range or a target.
SexAge5th25thMedian75th95thnCycle / source
All20-390.430.490.560.640.771,465NHANES 2017-2018
All40-590.470.540.590.660.801,577NHANES 2017-2018
All60+0.490.570.620.680.781,845NHANES 2017-2018
Allall0.450.530.590.660.794,887NHANES 2017-2018
Men20-390.420.490.550.620.72709NHANES 2017-2018
Men40-590.470.550.590.650.77745NHANES 2017-2018
Men60+0.490.560.620.670.75950NHANES 2017-2018
Menall0.440.530.590.650.752,404NHANES 2017-2018
Women20-390.430.490.560.670.81756NHANES 2017-2018
Women40-590.450.520.600.690.82832NHANES 2017-2018
Women60+0.490.570.630.690.80895NHANES 2017-2018
Womenall0.450.530.600.680.812,483NHANES 2017-2018

What studies found when this marker was changed

They describe what happened in those study groups, not a recommendation. See all catalogued interventions.

Measured changes in WHtR, study by study

1 effect with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.

Each row is one study: what was changed, the effect it reported on this marker, and the source.
TypeInterventionReported effectEvidenceSource
pharmacologicSubcutaneous semaglutide 2.4 mg once weekly for up to 4 years in adults with overweight/obesity and cardiovascular disease without diabetesWaist-to-height ratio -6.9% with semaglutide vs -1.0% with placebo at 208 weeksRCTRyan DH, Lingvay I, Deanfield J, et al. Nat Med. 2024.

Sources